GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PT Kalbe Farma Tbk (OTCPK:PTKFF) » Definitions » Gross Margin %

PT Kalbe Farma Tbk (PT Kalbe Farma Tbk) Gross Margin % : 39.71% (As of Mar. 2024)


View and export this data going back to 2010. Start your Free Trial

What is PT Kalbe Farma Tbk Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. PT Kalbe Farma Tbk's Gross Profit for the three months ended in Mar. 2024 was $215 Mil. PT Kalbe Farma Tbk's Revenue for the three months ended in Mar. 2024 was $542 Mil. Therefore, PT Kalbe Farma Tbk's Gross Margin % for the quarter that ended in Mar. 2024 was 39.71%.

Warning Sign:

PT Kalbe Farma Tbk gross margin has been in long-term decline. The average rate of decline per year is -3.6%.


The historical rank and industry rank for PT Kalbe Farma Tbk's Gross Margin % or its related term are showing as below:

PTKFF' s Gross Margin % Range Over the Past 10 Years
Min: 38.54   Med: 46   Max: 48.97
Current: 38.54


During the past 13 years, the highest Gross Margin % of PT Kalbe Farma Tbk was 48.97%. The lowest was 38.54%. And the median was 46.00%.

PTKFF's Gross Margin % is ranked worse than
65.28% of 988 companies
in the Drug Manufacturers industry
Industry Median: 46.48 vs PTKFF: 38.54

PT Kalbe Farma Tbk had a gross margin of 39.71% for the quarter that ended in Mar. 2024 => Competition eroding margins

The 5-Year average Growth Rate of Gross Margin for PT Kalbe Farma Tbk was -3.60% per year.


PT Kalbe Farma Tbk Gross Margin % Historical Data

The historical data trend for PT Kalbe Farma Tbk's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PT Kalbe Farma Tbk Gross Margin % Chart

PT Kalbe Farma Tbk Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 45.26 44.33 42.97 40.45 38.83

PT Kalbe Farma Tbk Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 40.92 40.44 37.00 36.97 39.71

Competitive Comparison of PT Kalbe Farma Tbk's Gross Margin %

For the Drug Manufacturers - General subindustry, PT Kalbe Farma Tbk's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PT Kalbe Farma Tbk's Gross Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, PT Kalbe Farma Tbk's Gross Margin % distribution charts can be found below:

* The bar in red indicates where PT Kalbe Farma Tbk's Gross Margin % falls into.



PT Kalbe Farma Tbk Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

PT Kalbe Farma Tbk's Gross Margin for the fiscal year that ended in Dec. 2023 is calculated as

Gross Margin % (A: Dec. 2023 )=Gross Profit (A: Dec. 2023 ) / Revenue (A: Dec. 2023 )
=766.9 / 1975.164
=(Revenue - Cost of Goods Sold) / Revenue
=(1975.164 - 1208.218) / 1975.164
=38.83 %

PT Kalbe Farma Tbk's Gross Margin for the quarter that ended in Mar. 2024 is calculated as


Gross Margin % (Q: Mar. 2024 )=Gross Profit (Q: Mar. 2024 ) / Revenue (Q: Mar. 2024 )
=215.4 / 542.49
=(Revenue - Cost of Goods Sold) / Revenue
=(542.49 - 327.046) / 542.49
=39.71 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


PT Kalbe Farma Tbk  (OTCPK:PTKFF) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

PT Kalbe Farma Tbk had a gross margin of 39.71% for the quarter that ended in Mar. 2024 => Competition eroding margins


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


PT Kalbe Farma Tbk Gross Margin % Related Terms

Thank you for viewing the detailed overview of PT Kalbe Farma Tbk's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


PT Kalbe Farma Tbk (PT Kalbe Farma Tbk) Business Description

Traded in Other Exchanges
Address
Jalan Let. Jend. Suprapto Kav. 4, Gedung KALBE, Cempaka Putih, Jakarta, IDN, 10510
Kalbe Farma is a drug manufacturing company that focuses on prescription pharmaceuticals, over-the-counter drugs, energy drinks, and nutrition products. The company operates four segments: prescription pharmaceuticals, consumer health, Nutritionals, and distribution and logistics. Majority of the company's gross profits are derived from the distribution and logistics segments. The company primarily operates in Indonesia but has operations across various ASEAN countries, Nigeria, and South Africa.

PT Kalbe Farma Tbk (PT Kalbe Farma Tbk) Headlines

No Headlines